Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits
about
Epistatic interactions in genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systemsIncreased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based StudyThe Association of the Metabolic Syndrome with PAI-1 and t-PA LevelsPAI-1 antagonists: the promise and the peril.Markers associated with sex differences in methamphetamine-induced striatal dopamine neurotoxicity.Shadows of complexity: what biological networks reveal about epistasis and pleiotropy.Serum uric acid is associated with increased risk of idiopathic venous thromboembolism in high HDL-C population: A case-control studyThe association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian populationHigh-density lipoprotein as a modulator of platelet and coagulation responses.Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo.Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women.Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.Markers of inflammation and fibrinolysis in relation to outcome after surgery for lumbar disc herniation. A prospective study on 177 patients.Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity
P2860
Q30999425-8D270D20-B5E0-41F4-AC72-775E7A148219Q33623576-6EBCC6D8-6BD1-492F-B710-CE7ADEA09A5DQ33697706-87A4ED45-DCA5-4ECD-845B-F2AA013B2959Q33726132-D8209892-1C14-4D28-A29B-736A8C93CD41Q34929646-ED2B1F53-5667-4BCF-8110-607484E288EAQ35048985-1AD36680-8AD1-4E0A-8568-1C5217EC369AQ35107869-02CF8281-1ACD-49DF-A590-62163C059DC6Q35176193-47E4E7B2-0795-4037-8079-B23F9B048399Q36953499-D197AA26-A829-411A-B7B8-97CEF128C2FBQ37355492-FC5B4D38-B65A-46F3-8F15-B1BC6F52DE9AQ37406181-90775FC2-7A9B-433D-99D5-E3659372B2B9Q38217201-4D0C7ACC-6FE1-4324-B023-68C3D3E92C0AQ43023689-5BA8B8A6-6099-4ADD-AFA4-345E53B6C497Q43961943-00ACDA6A-5A56-47FD-93C0-471D57DEE2A2Q46178310-ECCA9F6C-A822-4C8E-A831-95B8AF76CEB5Q48188580-8E794DEB-540E-48B0-A6BD-D5FCCD652DC5Q56774912-27B52405-5071-4445-82B7-77669CE4A84D
P2860
Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits
description
im November 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 09 November 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2007
@uk
name
Gender-specific correlations o ...... ascular disease-related traits
@en
Gender-specific correlations o ...... ascular disease-related traits
@nl
type
label
Gender-specific correlations o ...... ascular disease-related traits
@en
Gender-specific correlations o ...... ascular disease-related traits
@nl
prefLabel
Gender-specific correlations o ...... ascular disease-related traits
@en
Gender-specific correlations o ...... ascular disease-related traits
@nl
P2093
P2860
P50
P1476
Gender-specific correlations o ...... ascular disease-related traits
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2007.02311.X
P577
2006-11-09T00:00:00Z